Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
01 3Omgene Life Sciences Pvt. Ltd
02 42care4
03 15Abacus Medicine
04 1Amryt Pharma
05 2Ascent Innovative Medicines
06 5Avet Pharmaceuticals
07 5Bioindustria L.I.M. Spa
08 3Biological E
09 1CHIESI USA INC
10 4Campus Pharma AB
11 1Cc Pharma Nordic Aps
12 3Central Procurement & Supplies Unit
13 6Chemi SpA
14 2Cherubino Limited
15 1EJ Busuttil Ltd
16 3Ebb Medical
17 1Farmak JSC
18 2Flagship Biotech International Pvt. Ltd
19 9Fresenius Kabi AB Brunna
20 5Fresenius Kabi USA
21 4GLAND PHARMA LIMITED
22 7GP Pharm
23 12Generic Health
24 1Hainan Shuangcheng Pharmaceuticals
25 8Hospira, Inc.
26 7Italfarmaco S.p.A
27 3LIFEPHARMA SpA
28 1LYOMARK PHARMA GMBH DE 82041 Oberhaching near Munick
29 4Labatec Pharm
30 3Lifepharma
31 15Medartuum
32 5Meitheal Pharmaceuticals
33 3Mepha Pharma
34 2Montage Laboratories
35 4Naprod Life Sciences
36 3Northern Medical Group Aps
37 54Novartis Pharmaceuticals Corporation
38 6Novartis South Africa (Pty) Ltd
39 13ORIFARM GROUP AS
40 4Omega Laboratories Limited
41 7Paranova Pharmaceuticals Ab
42 6Pfizer Inc
43 3Pluviaendo
44 3Ratiopharm Espana Sa
45 5Sagent Pharmaceuticals
46 37Sun Pharmaceutical Industries Limited
47 12Teva Pharma Australia
48 16Teva Pharmaceutical Industries
49 2Uab Bijon Medica
50 9Unimedic AB
51 1Varian Pharmed
52 3Viatris
53 5West-ward Pharmaceutical Corp
54 5Wockhardt
01 1Ampoule
02 1CAPSULE, DELAYED RELEASE;ORAL
03 1Capsule
04 2INF
05 6INJ
06 59INJECTABLE;INJECTION
07 3Injectable And Infusion Solution
08 3Injectable And Perfusion Solution
09 57Injectable Solution
10 3Injectable Suspension
11 5Injection
12 11Injection fluid, resolution
13 2KIT
14 2Liquid Injection
15 4Lyophilised Injection
16 1Octreotide 0.05Mg 10 Units Parenteral Use
17 1Octreotide 0.1Mg 10 Units Parenteral Use
18 1Octreotide 0.5Mg 10 Units Parenteral Use
19 1Octreotide 0.5Mg 3 Units' Parenteral Use
20 5Octreotide 100Mcg 5 Units Parenteral Use
21 1Octreotide 10Mg 1 Unit Parenteral Use
22 4Octreotide 1Mg 1 Unit Parenteral Use
23 1Octreotide 20Mg 1 Unit Parenteral Use
24 1Octreotide 30Mg 1 Unit Parenteral Use
25 4Octreotide 500Mcg 5 Units Parenteral Use
26 5Octreotide 50Mcg 5 Units Parenteral Use
27 4POWDER FOR SUSPENSION, SUSTAINED-RELEASE
28 3Powder And Solvent For Extended-Release Injectable Suspension
29 7Powder And Solvent For Injectable Suspension
30 6Powder And Solvent For Prolonged-Release Injectable Suspension
31 31Powder For Injection
32 1Powder and liquid to the injection fluid, suspension
33 2Pre-Filled Syringe
34 5SOLUTION
35 1SOLUTION;SUBCUTANEOUS
36 1Solution
37 30Solution For Injection
38 4Solution For Injection And Infusion
39 5Solution For Injection In Pre-Filled
40 1Solution For Injection In Pre-Filled Syringe
41 1Solution For Injection Or Concentrate For Solution For Infusion
42 10Solution For Injection/Infusion
43 1Solution for Injection
44 3Vial
45 18injection
46 30Blank
01 13Allowed
02 41Approved
03 10Authorised
04 12Authorized
05 10Cancelled
06 18DISCN
07 62Deregistered
08 4Generic
09 6Originator
10 11Prescription
11 43RX
12 4Withdrawn
13 115Blank
01 1BYNFEZIA PEN
02 4Longastatina
03 3Longastatina Lar
04 1MYCAPSSA
05 1Mycapssa
06 36OCTREOTIDE ACETATE
07 12OCTREOTIDE ACETATE (PRESERVATIVE FREE)
08 4OCTREOTIDE ACETATE OMEGA
09 3OCTREOTIDE ACETATE PRESERVATIVE FREE
10 1OCTREOTIDE BIOINDUSTRY LIM
11 3OCTREOTIDE FOR INJECTABLE SUSPENSION
12 4OCTREOTIDE SUN
13 1OCTREOTIDE TEVA 20
14 1OCTREOTIDE TEVA 30
15 1Octra
16 2Octreo-Ratiopharm
17 4Octreotida Gp-Pharm
18 2Octreotida Hospira
19 3Octreotida Ratiopharm
20 4Octreotida Sun
21 3Octreotida Teva
22 17Octreotide
23 6Octreotide (SUN)
24 3Octreotide 2Care4
25 3Octreotide Abacus Medicine
26 3Octreotide Acetate
27 6Octreotide Acetate Omega (Canada)
28 2Octreotide Bendalis
29 2Octreotide Bijon
30 4Octreotide Campus
31 3Octreotide Csc
32 12Octreotide Depot
33 6Octreotide Fresenius Kabi
34 6Octreotide GH
35 8Octreotide Hospira
36 4Octreotide Labatec
37 2Octreotide Orifarm
38 4Octreotide Sun
39 6Octreotide Teva
40 3Octreotide-Mepha LA
41 1Octroflex
42 4Oktreotid SUN
43 2Olatuton
44 6SANDOSTATIN
45 6SANDOSTATIN LAR
46 3SIROCTID
47 46Sandostatin
48 1Sandostatin 1Mg/5Ml Injection
49 2Sandostatin 0.05
50 2Sandostatin 0.1
51 2Sandostatin 0.5
52 1Sandostatin ALLOWS
53 12Sandostatin LAR
54 3Sandostatin LAR Fertigspritzen
55 34Sandostatin Lar
56 1Sandostatin Lar 10Mg
57 1Sandostatin Lar 20Mg
58 1Sandostatin Lar 30Mg
59 3Sandostatina
60 3Siroctid
61 3TREOJECT
62 3Treoject
63 15Blank
01 48Australia
02 11Canada
03 16India
04 1Iran
05 36Italy
06 14Malta
07 12Norway
08 8South Africa
09 22Spain
10 103Sweden
11 13Switzerland
12 3Turkey
13 61USA
14 1Ukraine
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name : Octreotide Acetate
Dosage Form : Injectable Suspension
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name : Octreotide Acetate
Dosage Form : Injectable Suspension
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name : Octreotide Acetate
Dosage Form : Injectable Suspension
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Octreotida Gp-Pharm
Dosage Form : Injectable And Infusion Solution
Dosage Strength : 0.1MG
Packaging :
Approval Date : 2008-01-21
Application Number : 69524
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Octreotida Gp-Pharm
Dosage Form : Injectable And Infusion Solution
Dosage Strength : 0.0 5MG
Packaging :
Approval Date : 2008-01-17
Application Number : 69523
Regulatory Info : Cancelled
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Octreotida Gp-Pharm
Dosage Form : Solution
Dosage Strength : 1MG
Packaging :
Approval Date : 2008-01-21
Application Number : 69525
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.05MG BASE/ML
Packaging :
Approval Date : 1988-10-21
Application Number : 19667
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.1MG BASE/ML
Packaging :
Approval Date : 1988-10-21
Application Number : 19667
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.5MG BASE/ML
Packaging :
Approval Date : 1988-10-21
Application Number : 19667
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1991-06-12
Application Number : 19667
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1991-06-12
Application Number : 19667
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN LAR
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 10MG BASE/VIAL
Packaging :
Approval Date : 1998-11-25
Application Number : 21008
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN LAR
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 20MG BASE/VIAL
Packaging :
Approval Date : 1998-11-25
Application Number : 21008
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN LAR
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 30MG BASE/VIAL
Packaging :
Approval Date : 1998-11-25
Application Number : 21008
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Sandostatin
Dosage Form : Injectable And Perfusion Solution
Dosage Strength : 1000MCG
Packaging :
Approval Date : 1993-03-01
Application Number : 59560
Regulatory Info : Cancelled
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Sandostatin
Dosage Form : Injectable And Perfusion Solution
Dosage Strength : 100MCG
Packaging :
Approval Date : 1993-03-01
Application Number : 59559
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Octreotida Hospira
Dosage Form : Injectable Solution
Dosage Strength : 100MCG
Packaging :
Approval Date : 2008-11-10
Application Number : 70240
Regulatory Info : Cancelled
Registration Country : Spain
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Octreotida Sun
Dosage Form : Injectable Solution
Dosage Strength : 500MCG
Packaging :
Approval Date : 2017-10-11
Application Number : 74583
Regulatory Info : Cancelled
Registration Country : Spain
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Octreotida Sun
Dosage Form : Injectable Solution
Dosage Strength : 50MCG
Packaging :
Approval Date : 2017-10-11
Application Number : 74585
Regulatory Info : Cancelled
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Octreotida Teva
Dosage Form : Powder And Solvent For Prolonged-Release Injectable Suspension
Dosage Strength : 20MG
Packaging :
Approval Date : 2019-06-28
Application Number : 84223
Regulatory Info : Authorized
Registration Country : Spain
Contact Us!
